| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55cde26ef04bb85d0a195b5f2dc56441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cb6e0561c830115d59272ab1fb819a4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10123 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 |
| filingDate |
2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46675ba7d5de06e26ae2c2515dbb2ae0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16cf0f6636f9b531231916d4cadc997
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bdd3660b024eed033868047a0e95072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0705ff8a27c672d50a19525b47911efe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19571fef8f8a34f09cb71e62e7640d74 |
| publicationDate |
2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017210181-A1 |
| titleOfInvention |
Compositions and methods for generating an immune response to hepatitis b virus |
| abstract |
The compositions and methods are described for generating an immune response to a hepatitis B virus. The compositions and methods described herein relate to a modified vaccinia Ankara (MVA) vector encoding one or more viral antigens for generating a protective immune response to a hepatitis B virus, in the subject to which the vector is administered. The compositions and methods of the present invention are useful both prophylactically and therapeutically and may be used to prevent and/or treat an infection caused by hepatitis B virus. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413341-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278607-B2 |
| priorityDate |
2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |